Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ/su vaccine in adults with hematologic malignancies
2012-003438-18Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing HZ/su vaccine with Placebo (2 arms). Primary endpoints: Occurrence of solicited local and general symptoms and Safety and reactogenicity from first vaccination up to 30 days post last vaccination. Started Nov 2012; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2012-003438-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003438-18.